Latest / The Well-Built Life / Navigating Panic Disorder: Origins, Mechanisms, and Management
Transcript
- 0:00Speaker 1: Hey everyone, welcome back to The Well-Built Life. I am
- 0:03Speaker 1: Rachel Caldwell, alongside Thomas Bennett, and we are so glad
- 0:06Speaker 1: you are tuning in. We are here to cut through
- 0:09Speaker 1: the noise, skip the intense jargon and extreme rules, and
- 0:13Speaker 1: share simple practical habits that help you feel stronger, healthier,
- 0:16Speaker 1: and more balanced every single day. Grab a drink, get comfortable,
- 0:21Speaker 1: and let's dive in. Welcome Thomas. Let's dive into the
- 0:24Speaker 1: complex world of panic disorder. It's a condition that can
- 0:28Speaker 1: dramatically affect a person's daily life. But to fully understand it,
- 0:32Speaker 1: we need to explore the root mechanisms and how they unfold.
- 0:36Speaker 2: Absolutely, Rachel. First, a broad overview. The typical onset of
- 0:40Speaker 2: panic disorder is usually in early to mid-adulthood, but it
- 0:44Speaker 2: can crop up at any age. This condition is essentially
- 0:48Speaker 2: a combination of emotional and autonomic responses kicking into overdrive
- 0:53Speaker 2: thanks to a hyperactive amygdala. Right.
- 0:56Speaker 1: And that's the crucial nuance here, the amygdala. This little
- 1:00Speaker 1: almond-shaped structure in the brain acts like a primary alarm system,
- 1:05Speaker 1: and in panic disorder, it's sending out unnecessary alerts, leading
- 1:09Speaker 1: to those intense panic attacks.
- 1:11Speaker 2: Exactly, which brings up an interesting contradiction between genetics and environment.
- 1:17Speaker 2: Twin studies and adoption studies have shown that genetics do
- 1:20Speaker 2: play a significant role, but environmental stressors can also exacerbate
- 1:25Speaker 2: the condition. Therese, no one-size-fits-all answer here.
- 1:29Speaker 1: Exactly. But speaking of environments, let's talk about the core mechanisms.
- 1:34Speaker 1: The sympathetic nervous system, SNS, and the locus coeruleus work
- 1:39Speaker 1: together to heighten the fight-or-flight response. But the insula can
- 1:43Speaker 1: sometimes misinterpret normal bodily sensations as threats. It's a bit
- 1:47Speaker 1: of a feedback loop, isn't it?
- 1:49Speaker 2: Precisely. The insula is particularly interesting. It's like the body's
- 1:55Speaker 2: internal weather service. And in people with panic disorder, it
- 1:59Speaker 2: might be sending out a hurricane of sensations. And the
- 2:02Speaker 2: ventral medial prefrontal cortex, VMPFC, and raphe nuclei are there
- 2:07Speaker 2: to try and calm things down. But they might not
- 2:10Speaker 2: always do the job effectively. Right.
- 2:13Speaker 1: So let's zoom out a bit and talk about the prevalence.
- 2:16Speaker 1: Roughly 2-3% of adults will experience panic disorder in their lifetime.
- 2:21Speaker 1: And unfortunately, it's more common among women. but the good
- 2:25Speaker 1: news is that early intervention can really make a difference.
- 2:28Speaker 2: Exactly. And the onset age is typically between 15 and 40,
- 2:33Speaker 2: averaging around 25. But the interesting part is, despite the
- 2:37Speaker 2: potential for chronicity, many people do manage to make significant
- 2:41Speaker 2: strides with treatment. Therese, an ongoing debate about whether psychotherapy, pharmacotherapy,
- 2:47Speaker 2: or a combination approach might be most effective.
- 2:50Speaker 1: That's true. Speaking of which... let's dive a bit deeper
- 2:54Speaker 1: into the treatment landscape. Therese, this complex interaction of drugs,
- 2:58Speaker 1: like SSRIs and beta blockers, trying to work alongside talk therapy, mindfulness,
- 3:04Speaker 1: and lifestyle changes. It's fascinating how these different elements can
- 3:09Speaker 1: sometimes complement each other or clash.
- 3:11Speaker 2: Indeed. And even as we understand more about the neurological
- 3:15Speaker 2: underpinnings of panic disorder, Therese still a lot of room
- 3:18Speaker 2: for innovation. For instance, non-invasive brain stimulation techniques like transcranial
- 3:24Speaker 2: magnetic stimulation TMS could be game changers. They might offer
- 3:29Speaker 2: a way to directly target that overactive amygdala.
- 3:32Speaker 1: That's wild when you look at the raw numbers. And
- 3:34Speaker 1: as we move forward, I think we will see more
- 3:37Speaker 1: emphasis on personalized medicine, where treatments are tailored to individual biomarkers,
- 3:42Speaker 1: and tools like mobile apps and online support groups might
- 3:46Speaker 1: become essential in helping people manage their symptoms.
- 3:49Speaker 2: Definitely. Those tools can offer a sense of community and
- 3:53Speaker 2: real-time support, making it easier for people to navigate their
- 3:56Speaker 2: panic disorder. It's a multifaceted condition, but with the right
- 4:01Speaker 2: tools and understanding, we can help many people live fuller,
- 4:05Speaker 2: healthier lives.
- 4:06Speaker 1: Let's focus on the core neurological mechanisms behind panic attacks.
- 4:12Speaker 1: Starting with the amygdala, it's often described as our brain's
- 4:16Speaker 1: alarm system. Can you explain its role, Thomas?
- 4:19Speaker 2: Absolutely, Rachel. The amygdala is crucial because it's responsible for
- 4:24Speaker 2: detecting threats and signaling the body to enter a fight-or-flight mode.
- 4:28Speaker 2: Imagine this as the brain's security guard, always on high alert.
- 4:32Speaker 2: When it perceives a threat, it triggers the release of
- 4:35Speaker 2: hormones like adrenaline, which can lead to the physical symptoms
- 4:39Speaker 2: we experience during a panic attack.
- 4:41Speaker 1: Got it. So, the amygdala is essentially the starting point
- 4:45Speaker 1: for the entire ordeal. But how does it get triggered?
- 4:49Speaker 2: Well, the amygdala receives information from both external and internal sources.
- 4:54Speaker 2: For example, if you are in a situation where you
- 4:57Speaker 2: perceive a threat, like seeing a snake, your amygdala goes
- 5:00Speaker 2: into overdrive. It can also be triggered by internal cues,
- 5:04Speaker 2: such as an increase in heart rate or sweating. These
- 5:07Speaker 2: sensations can trick the brain into thinking to raise a
- 5:10Speaker 2: real and immediate threat.
- 5:12Speaker 1: It's almost like the amygdala is hypervigilant. But what happens
- 5:16Speaker 1: next in the body?
- 5:17Speaker 2: Once the amygdala signals a threat, it activates the sympathetic
- 5:21Speaker 2: nervous system. This is the part of the autonomic nervous
- 5:25Speaker 2: system that controls our fight or flight response. It's like
- 5:29Speaker 2: the brain saying, hey, everything is going to hell, and
- 5:32Speaker 2: we need to prepare for it. The sympathetic nervous system
- 5:36Speaker 2: then floods the body with stress hormones, like cortisol and adrenaline,
- 5:41Speaker 2: causing our heart rate to increase. our muscles to tense,
- 5:45Speaker 2: and our breathing to speed up.
- 5:46Speaker 1: So, it's almost like the amygdala and the sympathetic nervous
- 5:50Speaker 1: system are in a constant state of readiness. But isn't
- 5:54Speaker 1: there a brake system involved? Something to calm this down?
- 5:58Speaker 2: You are right. That's where the ventral medial prefrontal cortex, VMPFC,
- 6:05Speaker 2: and the raphe nuclei come into play. These areas are
- 6:09Speaker 2: like the brain's calming mechanisms. The VMPFC normally steps in
- 6:14Speaker 2: to analyze the situation, and, when it's appropriate, it calms
- 6:18Speaker 2: the amygdala by increasing the presence of neurotransmitters like GABA
- 6:22Speaker 2: and serotonin. It's like the valet parking system telling the amygdala,
- 6:27Speaker 2: the coast is clear, chill out.
- 6:29Speaker 1: That's a great analogy. But if the amygdala is so sensitive,
- 6:33Speaker 1: can it sometimes misinterpret normal sensations as threats?
- 6:37Speaker 2: Exactly. This is a key point, Rachel. In panic disorder,
- 6:41Speaker 2: the insula, which processes bodily sensations, can malfunction. It might
- 6:46Speaker 2: misinterpret normal body activities like a fast heartbeat as life-threatening dangers.
- 6:51Speaker 2: This misinterpretation gets amplified by the amygdala, leading to a
- 6:55Speaker 2: false alarm. It's like the brain's spam filter misidentifies important
- 7:00Speaker 2: emails as junk, causing a false alert.
- 7:03Speaker 1: And this is where the panic attack really takes shape. So,
- 7:07Speaker 1: what happens if the panic attack keeps happening repeatedly?
- 7:10Speaker 2: Over time, repeated panic attacks can lead to chronic anxiety
- 7:14Speaker 2: and further dysregulation of the amygdala and its connections. The
- 7:18Speaker 2: brain becomes accustomed to this heightened state of alertness, making
- 7:22Speaker 2: it harder to calm down. It's like your immune system
- 7:25Speaker 2: getting too sensitized to normal pathogens, leading to a constant
- 7:28Speaker 2: state of inflammation.
- 7:30Speaker 1: That's fascinating. It almost feels like this cycle could become
- 7:33Speaker 1: harder to break as time goes on. But do we
- 7:37Speaker 1: have any tools or treatments to help manage this?
- 7:40Speaker 2: Absolutely. Therapies like cognitive behavioral therapy, CBT, can help address
- 7:47Speaker 2: the cognitive distortions that fuel panic attacks. Medications can also
- 7:52Speaker 2: play a role by targeting the amygdala's activity. However, the
- 7:57Speaker 2: key is often integrating these approaches with lifestyle changes and
- 8:01Speaker 2: self-care practices. For instance, mindfulness and stress reduction techniques can
- 8:06Speaker 2: help teach the brain to recognize and manage triggers more effectively.
- 8:10Speaker 1: It's clear that understanding these mechanisms is crucial for treatment.
- 8:15Speaker 1: But how do these insights translate into practical advice for
- 8:19Speaker 1: someone dealing with panic attacks?
- 8:21Speaker 2: Great question. First, recognizing the role of the amygdala and
- 8:25Speaker 2: the broader neurological pathways can give people a sense of control.
- 8:30Speaker 2: They understand that their panic isn't a sign of weakness,
- 8:33Speaker 2: but rather a malfunction that can be corrected. Secondly, techniques
- 8:37Speaker 2: like deep breathing and grounding exercises can help counteract the
- 8:40Speaker 2: amygdala's false alarms. Lastly, building a support network and using
- 8:45Speaker 2: digital tools like apps for tracking symptoms can help manage
- 8:49Speaker 2: and reduce the impact of panic attacks.
- 8:51Speaker 1: So, it's not just about treating the symptoms, but also
- 8:55Speaker 1: about understanding the underlying processes. This holistic approach is truly empowering.
- 9:02Speaker 1: Thanks for breaking it down, Thomas.
- 9:04Speaker 2: Anytime, Rachel. Understanding these mechanisms really helps in managing the condition.
- 9:09Speaker 2: Let's close by emphasizing that each person's experience is unique
- 9:13Speaker 2: and finding the right balance is key.
- 9:15Speaker 1: As we move into the treatments and what they really offer,
- 9:18Speaker 1: let's start with psychotherapy. It's often seen as a cornerstone
- 9:23Speaker 1: in managing panic disorder, especially cognitive behavioral therapy. CBT. Right, Thomas?
- 9:30Speaker 2: Exactly, Rachel. CBT works by challenging and changing thought patterns
- 9:35Speaker 2: that trigger panic symptoms. But Hera's The Nuance research shows
- 9:39Speaker 2: that not everyone responds the same way. Some find CBT
- 9:43Speaker 2: very effective, while others might need a more tailored approach.
- 9:47Speaker 1: Right. And what about pharmacotherapy? Let's peel back the layers
- 9:51Speaker 1: a bit more. SSRIs and other antidepressants are commonly prescribed,
- 9:56Speaker 1: targeting serotonin imbalance. but Therese been ongoing debate about their effectiveness.
- 10:02Speaker 1: How does that fit into the bigger picture?
- 10:04Speaker 2: Good point, Rachel. Therese evidenced that SSRIs can be effective,
- 10:08Speaker 2: but studies also show that their impact can vary widely.
- 10:12Speaker 2: For instance, a meta-analysis by the Cochrane Collaboration found that
- 10:16Speaker 2: while SSRIs have helped many, their overall effect size is moderate.
- 10:20Speaker 2: This means that while they work, Therese still room for improvement.
- 10:24Speaker 1: That's wild when you look at the raw numbers. On
- 10:27Speaker 1: the other hand, Therese, this fascinating area of complementary interventions, mindfulness, yoga,
- 10:34Speaker 1: and even diet changes, these are gaining traction. How do
- 10:38Speaker 1: these fit into the overall treatment landscape?
- 10:40Speaker 2: Absolutely interesting, Rachel. Mindfulness, for example, aims to train the
- 10:45Speaker 2: mind to focus on the present moment, reducing distress. Some
- 10:49Speaker 2: research suggests it can be as effective as CBT in
- 10:52Speaker 2: reducing panic attacks. The key, though, is finding what works
- 10:56Speaker 2: best for each person. Therese, no one-size-fits-all solution.
- 11:01Speaker 1: Exactly. Which brings up an interesting contradiction. While these complementary
- 11:06Speaker 1: practices show promise, Therese debate about their scientific rigor compared
- 11:11Speaker 1: to traditional treatments. How do we square that?
- 11:14Speaker 2: Great question. The challenge lies in comparing apples to oranges, really.
- 11:19Speaker 2: Traditional therapies have a long track record, but complementary approaches
- 11:23Speaker 2: are more recently gaining ground. Their integration into the healthcare
- 11:27Speaker 2: system is still evolving. For instance, a study published in
- 11:31Speaker 2: JAMA Psychiatry found that adding mindfulness to CBT didn't offer
- 11:35Speaker 2: significant additional benefits, sparking further debate.
- 11:39Speaker 1: That's a tough one. It's fascinating how the landscape is shifting,
- 11:43Speaker 1: but it also highlights the need for personalized approaches. What
- 11:47Speaker 1: about the longer-term outcomes? Are there any patterns emerging from
- 11:51Speaker 1: the research?
- 11:52Speaker 2: In the long term, the prognosis can vary widely. Some
- 11:55Speaker 2: people experience significant remission, but others might see a recurrence.
- 12:00Speaker 2: The debate here revolves around identifying those who need more
- 12:03Speaker 2: intensive support early on. Therese, an ongoing effort to develop
- 12:07Speaker 2: better predictive models based on biomarkers, which could help, but
- 12:10Speaker 2: we are still in the early stages.
- 12:12Speaker 1: That's the crux of the matter, Thomas. As we close,
- 12:16Speaker 1: it's clear that while we have some effective tools, Therese,
- 12:20Speaker 1: still a lot of work to do. Whether it's refining
- 12:23Speaker 1: traditional therapies, exploring new complementary practices, or developing personalized treatment plans,
- 12:29Speaker 1: the journey continues.
- 12:31Speaker 2: Well said, Rachel. It's about staying open to new insights
- 12:34Speaker 2: and innovations while acknowledging the complexities of this condition. The
- 12:38Speaker 2: ultimate goal is to find what works best for each
- 12:41Speaker 2: individual on their unique path to wellness.
- 12:44Speaker 1: As we move towards the future, it's important to acknowledge
- 12:47Speaker 1: the unresolved questions that still loom large in the field. Thomas,
- 12:52Speaker 1: what do you think are the key areas we need
- 12:54Speaker 1: to focus on when it comes to neuroimaging in the
- 12:57Speaker 1: context of panic disorder?
- 12:59Speaker 2: Great question, Rachel. Neuroimaging has been a game changer in
- 13:03Speaker 2: understanding the biological underpinnings of panic disorder. But the devil,
- 13:07Speaker 2: as they say, is in the details. Let's start with
- 13:10Speaker 2: the insula, often cited in studies due to its role
- 13:13Speaker 2: in interoception and the bodily sensations accompanying panic attacks. But
- 13:18Speaker 2: what are the precise mechanisms leading to its dysregulated activity?
- 13:22Speaker 1: Exactly. And that's where the complexity starts. We have imaging
- 13:27Speaker 1: studies showing altered connectivity in the insula and the amygdala,
- 13:32Speaker 1: but we need to pinpoint the exact neural pathways. How
- 13:36Speaker 1: do we bridge the gap between correlation and causation?
- 13:40Speaker 2: That's a critical point. Moving on. Let's talk about non-invasive
- 13:45Speaker 2: brain stimulation techniques like transcranial magnetic stimulation. Can they be
- 13:50Speaker 2: effective in modulating the hyperactive amygdala? The results are promising,
- 13:55Speaker 2: but we need more longitudinal studies to see if they
- 13:58Speaker 2: can deliver sustained benefits.
- 14:00Speaker 1: And while we are focusing on brain stimulation, what about
- 14:03Speaker 1: transcranial direct current stimulation, TDCs? How does it fit into
- 14:08Speaker 1: the bigger picture? It's seen as a less invasive alternative.
- 14:12Speaker 1: but we don't have enough data yet to fully understand
- 14:14Speaker 1: its potential.
- 14:15Speaker 2: Indeed, TDCs is intriguing. Another angle to consider is the
- 14:19Speaker 2: interaction between the autonomic and central nervous systems. How does
- 14:23Speaker 2: the physical response to stress like increased heart rate and
- 14:27Speaker 2: respiration interact with the brain's threat perception mechanisms? This interplay
- 14:31Speaker 2: seems key to the chronicity of the disorder.
- 14:33Speaker 1: Right. On the treatment side, personalized medicine approaches are gaining traction.
- 14:40Speaker 1: Tailoring treatment strategies based on individual biomarkers could offer a
- 14:44Speaker 1: more refined approach. However, how do we ensure these approaches
- 14:49Speaker 1: are accessible and feasible at scale?
- 14:51Speaker 2: That's a pragmatic question. Integration of digital health tools like
- 14:55Speaker 2: mobile apps and online support groups could enhance self-management and
- 15:00Speaker 2: access to care. These tools aren't just a one-way street.
- 15:04Speaker 2: They can also provide real-time data for personalized interventions. but
- 15:08Speaker 2: we need to ensure they remain accessible and effective.
- 15:11Speaker 1: Exactly. Speaking of tools, how do we see the future
- 15:15Speaker 1: of telehealth affecting mental health treatment? With the advancements in
- 15:19Speaker 1: digital health, will we see a shift where more people
- 15:23Speaker 1: are willing to access mental health services remotely?
- 15:26Speaker 2: Absolutely. Telehealth is already transforming care. It offers flexibility and convenience,
- 15:32Speaker 2: but it also raises questions about privacy and the quality
- 15:35Speaker 2: of care. As we move forward, We need to standardize
- 15:39Speaker 2: these platforms to ensure they meet the highest standards of care. True.
- 15:43Speaker 1: And what about the role of the ventral medial prefrontal cortex, VMPFC?
- 15:49Speaker 1: It's often mentioned in studies as a potential target for treatment.
- 15:53Speaker 1: How do we integrate this knowledge into our treatment protocols,
- 15:57Speaker 1: especially given its role in emotional regulation?
- 15:59Speaker 2: Good point. The VMPFC's involvement in inhibiting the amygdala is crucial.
- 16:05Speaker 2: But how do we translate this understanding into effective treatments?
- 16:09Speaker 2: We need more research to develop targeted interventions that can
- 16:12Speaker 2: modulate its activity without side effects. Agreed.
- 16:15Speaker 1: The journey ahead is certainly complex and multifaceted. But by
- 16:20Speaker 1: focusing on these areas and leveraging the advancements in neuroimaging
- 16:24Speaker 1: and digital health, we can make significant strides in improving
- 16:28Speaker 1: the lives of those living with panic disorder. So, as
- 16:31Speaker 1: we draw this to a close, let's reflect on a
- 16:34Speaker 1: few strategic implications. The long-term prognosis for someone with panic
- 16:38Speaker 1: disorder can be both promising and challenging. What do you think, Thomas?
- 16:44Speaker 1: How can we help individuals navigate this complex journey?
- 16:47Speaker 2: It's true, Rachel. The prognosis does vary based on several factors.
- 16:51Speaker 2: Early intervention and a multidisciplinary approach are key, but to
- 16:55Speaker 2: raise always the risk of chronicity, especially without proper management.
- 17:00Speaker 2: How can we support patients in integrating these strategies effectively?
- 17:04Speaker 1: Absolutely, Thomas. One crucial step is ensuring that treatment plans
- 17:08Speaker 1: are holistic. For instance, combining CBT with pharmacotherapy can be
- 17:13Speaker 1: more effective than a single approach. And digital health tools,
- 17:18Speaker 1: like apps for mindfulness and stress tracking, can offer continuous support.
- 17:23Speaker 1: How can we harness these tools better?
- 17:25Speaker 2: Exactly tools like those are game changers. They provide real-time
- 17:29Speaker 2: feedback and allow for more frequent check-ins. But it's also
- 17:33Speaker 2: vital to consider the role of support systems like peer
- 17:36Speaker 2: groups and family involvement. These can offer emotional and practical
- 17:41Speaker 2: support that's often underestimated.
- 17:43Speaker 1: True. Community engagement is incredibly important. It not only reduces isolation,
- 17:49Speaker 1: but also provides a sense of belonging. From a policy perspective, too.
- 17:54Speaker 1: There needs to be a focus on making mental health
- 17:57Speaker 1: services more accessible. How can we advocate for better mental
- 18:01Speaker 1: health infrastructure in our communities?
- 18:03Speaker 2: Advocacy is key, Rachel. We also need to address the
- 18:06Speaker 2: stigma surrounding mental health and provide education to reduce misconceptions.
- 18:11Speaker 2: That way, more people might feel comfortable seeking help. And
- 18:15Speaker 2: let's not forget the importance of ongoing research to tailor
- 18:19Speaker 2: treatment specifically for different demographics.
- 18:21Speaker 1: That's so true. Ongoing research is vital for understanding diverse needs.
- 18:27Speaker 1: For instance, knowing that women are more prone to panic
- 18:30Speaker 1: disorder can inform more tailored treatment strategies. But what about
- 18:35Speaker 1: those whose onset is in late adulthood? Their unique challenges
- 18:40Speaker 1: might need specific attention.
- 18:41Speaker 2: Exactly. Late-onset cases can be particularly difficult due to the
- 18:46Speaker 2: complex interplay of aging and psychological factors. Perhaps longitudinal studies
- 18:52Speaker 2: could shed more light on these nuances. And as for
- 18:55Speaker 2: the nature versus nurture debate, more precise genetic mapping could
- 18:58Speaker 2: help us understand who might be at greater risk.
- 19:01Speaker 1: Genetic and environmental factors definitely interact in complex ways. But
- 19:06Speaker 1: the point is, with a better understanding, we can develop
- 19:10Speaker 1: more targeted interventions. And technology could play a big role here.
- 19:15Speaker 1: Like AI-driven tools that help personalize treatment. based on individual needs.
- 19:21Speaker 2: AI-driven tools sound promising, but let's also not overlook the
- 19:25Speaker 2: value of traditional therapies. The human touch is irreplaceable, especially
- 19:30Speaker 2: for those who may have unique needs or preferences. A
- 19:34Speaker 2: balanced approach is key.
- 19:36Speaker 1: Agreed. A balanced approach that includes both technology and traditional
- 19:40Speaker 1: methods can offer the most effective outcome. And with all this,
- 19:44Speaker 1: we must remember to keep an open dialogue about the
- 19:47Speaker 1: ongoing challenges and successes in managing pandemics. disorder.
- 19:50Speaker 2: Absolutely. That dialogue will help us stay informed and continue
- 19:55Speaker 2: to improve our strategies. Whether it's through research, policy, or
- 19:59Speaker 2: community support, we need to keep pushing forward.
- 20:02Speaker 1: That brings us to the end of today's episode. Thank
- 20:05Speaker 1: you so much for spending part of your day with me.
- 20:08Speaker 1: If you found this episode's tips helpful and want to
- 20:11Speaker 1: make sure you don't miss the next conversation, please take
- 20:14Speaker 1: a quick second to hit that subscribe or follow button
- 20:17Speaker 1: on whatever platform you are listening on. It's a completely
- 20:20Speaker 1: free way to support the show and helps more people
- 20:22Speaker 1: find us. This podcast is independently produced, so if you
- 20:26Speaker 1: are ever in a position where you would like to
- 20:28Speaker 1: help keep it running, we do accept small donations. You
- 20:32Speaker 1: can find a link right in the episode description below
- 20:35Speaker 1: to buy us a coffee or contribute what you can.
- 20:38Speaker 1: Every bit genuinely helps. Take care of yourself, stay balanced,
- 20:43Speaker 1: and we will talk again soon.